Nectar Lifesciences Limited - Neraca (Quarterly)

Nectar Lifesciences Limited
IN ˙ NSEI
₹ 14.66 ↓ -0.03 (-0.20%)
2025-09-05
BAHAGING PRESYO
Talaan ng Balanse (Quarterly)

Neraca Nectar Lifesciences Limited menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2021
03-31
2021
09-30
2022
03-31
2022
09-30
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
Cash 279 255 160 178 141 176 200 198 182 192
Change (%) -8.39 -37.43 11.45 -21.04 25.02 13.97 -1.15 -7.91 5.38
Assets Current 15,233 12,388 12,843 13,548 12,765 12,312 12,081 12,838 13,054 12,376
Change (%) -18.67 3.67 5.49 -5.78 -3.55 -1.87 6.27 1.68 -5.20
Assets 25,348 23,881 23,682 23,908 22,884 21,892 21,427 21,911 21,832 20,472
Change (%) -5.79 -0.84 0.96 -4.29 -4.33 -2.12 2.26 -0.36 -6.23
Liabilities 14,241 13,261 13,025 13,029 12,190 11,246 10,753 11,218 11,054 10,911
Change (%) -6.88 -1.78 0.03 -6.44 -7.74 -4.39 4.33 -1.46 -1.29
Equity 11,107 10,620 10,657 10,879 10,694 10,646 10,674 10,692 10,778 9,561
Change (%) -4.38 0.34 2.08 -1.70 -0.45 0.27 0.17 0.80 -11.29
Liabilities And Stock Equity 25,348 23,881 23,682 23,908 22,884 21,892 21,427 21,911 21,832 20,472
Change (%) -5.79 -0.84 0.96 -4.29 -4.33 -2.12 2.26 -0.36 -6.23

Source: Capital IQ

Other Listings
IN:532649
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista